Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021
October 21 2021 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a
specialty pharmaceutical company developing medicines for
addictions and drug overdose, today announced it will report
third quarter 2021 financial results and pipeline updates
on Thursday, November 11, 2021, after U.S. financial markets
close.
The Company’s management team is scheduled to host a conference
call and webcast at 4:30 p.m. ET on Thursday,
November 11, 2021 to discuss the results and operational
progress.
To access the call, please dial 877-407-0792 in
the U.S. or 201-689-8263 outside the U.S. and
provide the conference ID number: 13723604. To access the live
webcast, please visit
http://public.viavid.com/index.php?id=146696. Following the
live webcast, an archived version of the call will be available on
the website.
Thursday November 11 @ 4:30 pm
ET
Domestic: |
877-407-0792 |
International: |
201-689-8263 |
Conference ID: |
13723604 |
Webcast: |
http://public.viavid.com/index.php?id=146696 |
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a leading franchise of
new medicines to combat addictions and drug overdose. For more
information visit: www.opiant.com and follow Opiant on Twitter
(@Opiant_Pharma).
For Media and Investor Inquiries:Ben Atkins,
Opiant(310) 598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Sep 2023 to Sep 2024